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a b s t r a c t
Human-wildlife conflicts are increasing worldwide. For instance, growing numbers of free-roaming feral
cattle in Hong Kong are causing traffic accidents and damaging crops. Public antipathy towards lethal
methods to manage wildlife has promoted research into alternative options, such as fertility control.
The aims of this study were to assess the potential side effects and effectiveness of the injectable
immunocontraceptive vaccine GonaCon on free-roaming feral cattle in Hong Kong. Sixty female cattle
were captured and randomly assigned to treatment or control groups. Treatment animals were adminis-
tered one dose of GonaCon, followed by a booster dose 3–6 months later. Control animals were admin-
istered an equivalent dose of a saline solution. The side effects of GonaCon were assessed by
monitoring injection site, body condition and body weight at vaccination, at the booster stage and one
year after initial vaccination. At the same times, blood samples were collected to quantify antibodies
to the vaccine and to assess pregnancy status. GonaCon did not affect the body weight or body condition
of cattle and had no adverse side effects such as injection site reactions, limping or abnormal behaviour.
GonaCon did not appear to interrupt ongoing pregnancies but reduced fertility significantly: the propor-
tion of pregnant animals in the GonaCon-treated group decreased from 76% at initial vaccination to 6%
one year after vaccination, compared to 67% and 57% respectively in the control group. There was no dif-
ference between antibody titres at the booster stage or one year post vaccination, suggesting the booster
dose maintained antibody levels. This study confirmed that GonaCon is safe and effective in inducing
infertility in feral cattle, with a booster dose critical for maintaining infertility.
Crown Copyright  2018 Published by Elsevier Ltd. All rights reserved.
1. Introduction
Human-wildlife conflicts, often associated with overabundant
animal populations, are increasing worldwide [36,17,12,24]. In
parallel, public antipathy to culling, traditionally used to mitigate
these conflicts, has grown because of concerns about animal wel-
fare, human safety in urban settings and environmental impact
of some culling methods [3,38,8]. This has promoted interest in
alternative options, such as fertility control, to manage overabun-
dant animal populations [10,11,16,6]. In particular, single-dose,
injectable immunocontraceptive vaccines are increasingly advo-
cated as alternative or complementary to culling for controlling
wildlife populations [21,9,25]. These vaccines act by inducing anti-
bodies to proteins or hormones essential for reproduction. One of
these contraceptives, an injectable, single-dose gonadotropin-
releasing hormone (GnRH) vaccine, GonaCon, significantly
decreased fertility for one to six years in white-tailed deer, Odo-
coileus virginianus, wild boar and feral pigs, Sus scrofa, cats, Felis
catus, horses, Equus caballus, and bison, Bison bison [31,19,27,26]).
GonaCon induces an immune response to the GnRH, which in turn
affects the cascade of reproductive hormones that lead to ovulation
[31]: following vaccination with GonaCon, females do not exhibit
oestrous [20]. In most species, the contraceptive effect of the vac-
cine decreases with time [30,26,35] although infertility can be
maintained for multiple years [18,14,23,39,29,22].
The side effects associated with the use of GonaCon in some
species include granulomatous nodules and sterile abscesses at
injection sites and in lymph nodes (white-tailed deer, Odocoileus
virginianus; [15]; elk, Cervus elaphus; [34] although no evidence
of limping or impaired mobility has been reported. Conversely,
no adverse effects were found in GonaCon-treated wild boar
[27,26], prairie dogs, Cynomys ludovicianus [39] or wild horses [16].
https://doi.org/10.1016/j.vaccine.2018.09.071
0264-410X/Crown Copyright  2018 Published by Elsevier Ltd. All rights reserved.
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In Hong Kong, feral cattle, Bos Taurus and Bos indicus, were tra-
ditionally used as draught animals. In the 1950 s, due to a decline
in agricultural activities, cattle were released into the wild by local
farmers. At present, most free-roaming feral cattle are located
away from the highly urbanised areas of Hong Kong in four main
areas: Lantau Island, Sai Kung/ Ma On Shan, Central New Territo-
ries and Northeast New Territories (Fig. 1). The impacts of feral cat-
tle include traffic disturbance and accidents, environmental
nuisance and crop damage. However, these animals are valued as
local heritage and some Hong Kong stakeholders support non-
lethal control to manage this species [1]. In 2011, the Agriculture
Fisheries and Conservation Department (AFCD) set up a Cattle
Management Team for the long-term management of feral cattle,
which in 2013 were estimated to be circa 1100 individuals [1].
One of the options the AFCD explored is surgical sterilisation: feral
cattle are captured and transported to the Cattle Team Operation
Center, surgically sterilised, and either returned to their natal area
or relocated to country parks. As capture and transport of cattle are
impossible in remote areas, immunocontraception was evaluated
in 2013 in captive trials as an alternative to surgical sterilisation
[28]. The captive study concluded that GonaCon was safe and
effective in reducing fertility in cattle as 8 of the 12 cows treated
with a single dose of GonaCon became infertile and all 10 control
cattle became pregnant. Cattle that had been surgically sterilized
through removal of the oviducts (thus still cycling) and adminis-
tered a booster dose had higher anti-GnRH antibody titres than
cattle that received a single dose [28]. The study concluded that
a booster dose was likely to be more effective in maintaining infer-
tility and suggested to test this hypothesis on free-roaming, non-
surgically sterilised cattle.
Building on these results, the aims of the present study were: 1)
to evaluate the effect of a primer and a booster dose of GonaCon on
the health and on the reproductive output of feral cattle; 2) to
assess the safety of GonaCon in animals that were pregnant when
vaccinated and; 3) to examine factors potentially affecting the
immune response of feral cattle vaccinated with GonaCon.
2. Methods
Due to the difficulty of recording body weights of cattle in the
field, a trial with captive cattle was carried out to assess the accu-
racy of body weight estimated by trained staff. The body weights of
19 cattle housed at the Operation Center were regressed against
independent estimates provided by three members of the Cattle
Team. The equation obtained from the regression of the mean esti-
mated body weight (EstBW) versus the actual body weight (BW) of
captive animals was BW = EstBW ⁄ 0.948 + 19.489 (Fig. 2). This
equation was used to calculate the body weight of feral cattle
(range: 150–420 kg for animals  1 year old).
Between June and August 2015, sixty feral female cattle from 13
locations (Fig. 1) were caught. A Power Analysis was carried out to
calculate the sample size required for treated and control animals.
This analysis was based on the expectation that at least 70% of the
cattle sampled would be pregnant (Cattle Team observations,
unpublished) and that two doses of GonaCon would render infer-
tile at least 75% of the animals. Based on the Power Analysis, the
sixty cattle were randomly assigned to Treatment (T: n = 42) or
Control (C: n = 18) groups. A dart gun (CO2 injection rifle, DAN-
INJECT ApS, Denmark) was used to administer a combination of
0.003 mg/kg etorphine/acepromazine (Immobilon, Novartis
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Fig. 1. Distribution of the cattle herds (filled squares) in Hong Kong. T = number of treated cattle; C = number of control cattle.
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Animal Health UK Ltd, Surrey, UK) and 0.4 mg/kg xylazine (Ilium
Xylazil-100, Troy Laboratories Pty. Limited, Australia) intramuscu-
larly. Treatment animals were given an intramuscular injection of
3 ml of GonaCon (1000 ug/ml of GnRH-mollusk-hemocyanin con-
jugate; lot number: GCRD05262015; USDA, Fort Collins, CO, USA)
in the neck. Control animals were injected with an equivalent vol-
ume of a 0.9% saline solution (Sodium Chloride Injection; Thai
Otsuka Pharmaceutical Co. Ltd., Thailand). Each animal was
marked with a numbered plastic and a metal ear tag (one tag per
ear) for remote identification. The following data were collected:
estimated body weight (in kg), estimated age, body condition score
and reproductive output. Age was assessed by tooth eruption and
replacement up to 4 years old [37] or estimated by tooth wear.
Body condition scores (BCS) were assigned on a scale of 1 to 5 with
1 = poorest condition, 3 = ideal and 5 = overweight [5]. Animals
were defined as reproductively active if observed either ‘‘lactating”
(the udder appeared extended or milk could be expressed when
the animal was sedated) or ‘‘with calf” (an animal was nursing a
calf or being followed by one). For each cow, 24 ml of blood was
collected in three untreated Vacutainers and one EDTA-treated
Vacutainer (BD Vacutainers, Plymouth, UK, 6 ml blood per Vacu-
tainer) for anti-GnRH antibody assays and for the pregnancy test.
The sera used for anti-GnRH antibody assays were stored at -
20 C until assayed. Once data were collected, anaesthesia was
reversed using a mixture of 0.003 mg/kg diprenorphine (Revivon,
Surrey, UK) and 2 mg/kg tolazoline (Lloyd Laboratories N.Z. Ltd.,
New Zealand) administered intravenously. Animals were observed
ad-hoc once a week (by the Cattle Team and by local Non-
Government Organisations (NGO)) for up to three months follow-
ing vaccination to monitor potential welfare issues.
Three to six months after initial vaccination (November 2015 to
January 2016), attempts were made to relocate as many of the
study animals as possible to collect blood samples (under anaes-
thesia, as described previously), administer a booster dose of the
vaccine and assess welfare. The T group was injected with 1 ml
of GonaCon and the C group was injected with 1 ml of saline solu-
tion. Eleven to 12 months after initial vaccination (May to July
2016), attempts were made to relocate as many of the study ani-
mals as possible to collect blood samples (under anaesthesia, as
described previously) to assess anti-GnRH antibody titre and
reproductive output. As animals were anaesthetised, it was not
possible to carry out a rectal palpation, commonly used to detect
pregnancy in this species [28]. The pregnancy status of animals
in T and C groups at initial vaccination, at the booster stage and
11–12 months after initial vaccination was assessed using a Rapid
Visual Pregnancy Test kit (IDEXX Laboratories, Inc., USA) for the
detection of the pregnancy-associated glycoproteins (PAGs) in
bovine serum, which are expressed from the second month of ges-
tation until calving [13]. The limitations of this test are that: (1)
PAGs can be detected 28 days post-breeding at the earliest, thus
early pregnancy cannot be determined and; (2) PAGs have a half-
life of 60 days, therefore a positive result may occur up to 60 days
post-calving. Therefore, the pregnancy status of cattle was inter-
preted based on both the PAGs pregnancy test and on direct obser-
vations of births of calves in the field. The following data were
collected at the booster dose stage and one year after vaccination:
estimated body weight, body condition score and reproductive
output (lactating, presence of a calf). Ad-hoc observations by the
Cattle Team or by NGOs established the date study animals gave
birth. Based on a nine month gestation [2]and on the approximate
date of birth of calves, the stage of pregnancy of all cattle at initial
vaccination was estimated.
The effectiveness of the vaccine to induce infertility was
assessed by: (1) the immune response to the vaccine, quantified
by measuring serum anti-GnRH antibodies; (2) pregnancy status
and (3) presence of a calf that could be attributed to a study ani-
mal. An enzyme-linked immunosorbent assay (ELISA) was used
to measure anti-GnRH antibody titres as described in Massei
et al. [28]. Anti-GnRH antibody titres were expressed as the highest
dilution at which the post-vaccination sample had a higher absor-
bance value than the mean (+2 SD) value of the pre-vaccination
samples. To eliminate potential for bias, the ELISA tests were per-
formed by a technician blinded to the original treatment group of
each serum sample.
2.1. Statistical analyses
Unless otherwise specified, statistical analyses were carried out
comparing data collected on T and C groups at initial vaccination,
booster dose and one year after vaccination (Table 1). In the linear
mixed effects models used to evaluate the effect of GonaCon on
body condition scores and on factors potentially affecting the
immune response to vaccination with GonaCon, cow identity was
Fig. 2. Body weight (in kg) of cattle (n = 19) in captivity, estimated independently
by three staff of the Cattle Team versus actual body weight.
Table 1
Description of the statistical analyses used throughout the study.
Test Used to evaluate
Wilcoxon-Mann-Whitney Age differences between cattle of T and C groups
Fisher’s exact Effect of GonaCon on health by comparing BCSs at initial vaccination and one year after vaccination. BSCs were pooled into two
categories:
Poor condition (score 1 or 2), Good condition (score, 3, 4 or 5)
Effect of GonaCon on reproductive output comparing:
1. Cattle in T and C groups which were pregnant, lactating or with calves at each stage
2. Pregnancy between younger cows (<1 and < 2 years old) and older cows (2 years old)
3. The number of T and C cattle that were pregnant at vaccination and that had given birth (based on field observations) to assess if
GonaCon interrupted pregnancies
4. The association between anti-GnRH antibody titres (pooled into three categories: Low (8), Medium (16  X  128), High (>128))
and infertility
Linear mixed effects models Effect of factors potentially affecting the immune response to vaccination with GonaCon
Wilcoxon for paired data Difference in the distribution of anti-GnRH antibody titres of cattle at the booster stage and one year after vaccination
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included as a random effect to account for repeated measures.
Treatment group, estimated age, stage of study and pregnancy sta-
tus at each stage were included as fixed effects. Generalized linear
mixed models were built using the nlme package in R version 3.2.4
[33]. Backwards stepwise selection based upon the Akaike infor-
mation criteria (AIC) was used to choose the optimal model.
3. Results
Of the sixty cattle captured, one T animal died under anaesthe-
sia and one C cattle had to be euthanised one month after vaccina-
tion, due to a maggot-infested ear infection. No injection site
reactions or any other abnormal behaviour were observed in ani-
mals in the T group in the months following vaccination. Three
to six months after initial vaccination, 51 (T: n = 38, C: n = 13) of
the remaining 58 animals (88%) were located and administered
the booster dose. Approximately one year after vaccination, 49
(T: n = 35, C: n = 14) of the remaining 58 animals (86%) were
located and sampled. At vaccination, there was no difference in
the age of cattle in T and C groups (w = 288.5, p = 0.410), which
ranged between 10 months and 12 years old (mean = 5.5 years,
SD = 3.3; C age range = 0.8–10 years; T age range = 0.8–12 years).
At initial vaccination, cattle in the T group were heavier than
those in the C group (t = 2.45, df = 57, p < 0.001). Body weight was
affected by age (t = 2.20, df = 96, p = 0.024); older animals were
heavier than younger ones. In the T group, there was no difference
between BCSs at vaccination and one year post vaccination
(p = 0.33), with 41 of 42 cattle assigned to good condition at vacci-
nation and 32 of 35 cattle assigned to good condition one year later.
At vaccination, 70% (42 out of 60) of all the animals were preg-
nant and there was no difference in the proportion of pregnant cat-
tle in T (76% i.e. 32 out of 42 animals) and C groups (67%, i.e. 12 out
of 18 animals) (p = 1.000) (Fig. 3). There was no difference in the
proportion of pregnant cattle in T (47%) and C (46%) groups at
the booster stage (p = 0.749). One year after vaccination, the pro-
portion of pregnant cattle in the T group (6%) was significantly dif-
ferent from that in the C group (57%) (p < 0.001).
There was no difference in the proportion of cattle lactating
between T and C groups at initial vaccination (T = 21%, C = 19%;
p = 1.000), at the booster stage (T = 37%, C = 25%; p = 0.510), or
one year after vaccination (T = 58%, C = 61%; p = 1.000). Similarly,
there was no difference in the proportion of cattle with calves at
initial vaccination (T = 42%, C = 25%; p = 0.360), at the booster stage
(T = 32%, C = 41%; p = 0.728), or one year after vaccination (T = 50%,
C = 54%; p = 1.000). Young age did not affect the proportion of
cattle found to be pregnant: the proportion of pregnant  1 year
old and < 2 year old cattle did not differ from that found in ani-
mals  2 years of age (p = 0.487 and p = 1.000 respectively).
Among the cattle that were found to be pregnant at vaccination,
29 births of calves in the T group (out of 32 cattle that were preg-
nant according to the blood test) and 10 births in the C group (out
of 12 cattle found pregnant according to the blood test) were
recorded by direct observation in the year following vaccination.
All 10 (100%) C animals and 28 out of 29 T cattle delivered a calf
in the year following vaccination. There was no difference
(p = 1.000) between the proportion of T and C cattle that were
pregnant at vaccination and that had given birth within a year.
For cattle in the T group, the 28 calves for which the date of birth
was available were born between 2 and 9 months after vaccination
(mean: 5.1 months, SD: 1.8).
All cattle in the T group developed anti-GnRH antibody titres.
The distribution of anti-GnRH antibody titres did not differ
between booster and one year after vaccination stages (v = 154.5,
p = 0.840) (Fig. 4). Cattle with a high anti-GnRH antibody titre
(>128) one year after vaccination were less likely to become preg-
nant than individuals with a lower titre (p < 0.0001, Table 2).
4. Discussion
The results of this study showed that GonaCon was safe when
administered to feral cattle as a single dose vaccination followed
by a booster dose three to six months later. No side effects of Gona-
Con treatment, such as injection site reactions or abnormal beha-
viour, were observed at any stage and GonaCon did not affect
body condition. These findings are consistent with previous stud-
ies, which found no general side effects or specific injection site
reactions in cattle or in several other species treated with GonaCon
(wild boar: [27,26]; cattle: [4,28].
Cattle in both treatment and control groups that were pregnant
at initial vaccination gave birth to calves in similar proportions,
showing that vaccinationwithGonaCondid not affect ongoing preg-
nancies. This also explained why there was no difference in the
proportion of females lactating or with calf between groups in the
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Fig. 4. Anti-GnRH antibody titre of treated cattle at booster vaccination and one
year after initial vaccination. Antibody titres expressed as  1000.
Table 2
Number of cattle found pregnant or not pregnant in relation to anti-GnRH antibody
titres recorded one year after animals had been vaccinated with GonaCon. Anti-GnRH
antibody titres are expressed as  1000 and pooled in three categories.: low (8),
medium (16  X  128) and high (>128).
Antibody Titre Not Pregnant Pregnant
Low (8) 4 1
Medium (16  X  128) 22 1
High (>128) 7 0
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year following vaccination. The birth dates of calves indicated that
births were widespread throughout the year and that animals had
been vaccinated at different stages of pregnancy. The fact that Gona-
Con does not appear to affect an ongoing pregnancy at any stage is
particularly important for field applications as feral cattle could be
treated (or administered booster doses) safely at any time of the
year.
This study indicated that two doses of GonaCon significantly
reduced reproduction in cattle as the percentage of pregnant
females decreased from 76% to 6% one year after vaccination,
against 67% to 57% recorded in the control group respectively. A
similar effect of GonaCon on infertility has been reported in several
species (using a primer and booster dose as in the current study),
including bison [32] and elk [34]. In female bison, four of the six
animals vaccinated with 1800 lg of GonaCon that were pregnant
at initial vaccination delivered healthy calves but they did not
reproduce the following season, whilst all five control animals pro-
duced calves [32]. Similarly, all ten elk vaccinated with 1500 lg of
GonaCon when pregnant delivered healthy calves but became
infertile in the years following vaccination [34].
In the current study, there was no significant difference between
the anti-GnRH antibody titres at the booster stage or one year post
vaccination, suggesting that the booster dose maintained antibody
levels. As expected, cattle with the highest levels of anti-GnRH anti-
body titres were less likely to be pregnant than those with lower
levels. Similarly, higher anti-GnRH antibody titres have been asso-
ciated with greater rates of infertility in other species, including
wild boar [27,26], feral horses [19] and white-tailed deer [16].
Long-term infertility for long-lived animals can only be
assessed in a multi-year study. Most multi-year studies of Gona-
Con found that in the years following vaccination, anti-GnRH anti-
body titres decreased and fertility was restored in some individuals
but not in others that remained infertile for many years
[19,30,14,26]. For instance, in captive wild boar treated with a sin-
gle dose of GonaCon, titres dropped significantly in the 18 months
following vaccination and then remained relatively low for the fol-
lowing 5 years [26] with 11 out of 12 female wild boar remaining
infertile for at least 5 years after vaccination.
Although the reversibility of the contraceptive effect can be
considered a disadvantage when fertility control is used to manage
overabundant populations of wildlife [7,11,25], temporary infertil-
ity might be desirable in other species, such as elephants and feral
horses [21,9,6]. For example, in elephants immunocontraception
was used to extend the inter-calving interval and give all females
the possibility of reproducing at a lower rate [9]. The latter might
be applicable to the Hong Kong cattle that many stakeholders want
to retain in the area.
In conclusion, this study confirmed that GonaCon is safe and
effectively induces infertility in cattle. Future field studies should
focus on the long-term monitoring of the study animals to assess
the longevity of the contraceptive effect. Additional research
should be conducted on the feasibility and sustainability of
immunocontraception at the herd level. For instance, modelling
could be used to determine the proportion of a herd that must
be vaccinated as well as the frequency of vaccination to achieve
a set reduction in herd size.
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